Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Pizzutto, Susan J ^a   Upham, John W ^b   Yerkovich, Stephanie T ^b   Chang, Anne B ^c  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT DISEASE; BRONCHIECTASIS; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; LENGTH OF STAY; QUALITY OF LIFE; REVIEW; SPIROMETRY; SYMPTOM; SYSTEMATIC REVIEW;

EID: 70249112576     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007525     Document Type: Review

References (22)

1. Behrman RE, Kliegman RM, Jenson HB. Nelson Textbook of Pediatrics. 17th Edition. Philadelphia: Saunders, 2003.
2. Cates C. Visual Rx. Online NNT Calculator. http: //www.nntonline.net/: Cates C, 2003.
3. AB Chang, D Bilton. Non-cystic fibrosis bronchiectasis exacerbations. Thorax 2008;63:269-276
4. Cole PJ. Inflammation: a two edged sword. Themodel of bronchiectasis. European Journal of Respiratory Disease 1986;147 Suppl:6-15.
5. Courtney, J, Kelly, M, Watt, A, Garske, L, Bradley, J, Ennis, M, Elborn, J. Quality of life and inflammation in exacerbations of bronchiectasis. Chron.Respir Dis 2008;5:161-168.
6. Crockett AJ, Cranston JM, Latimer KM, Alpers JH. Mucolytics for bronchiectasis (CochraneReview). CochraneDatabase of Systematic Reviews 2001, issue 1. [DOI: 10.1002/14651858.CD001289]
7. Cymbala, A.A, Edmonds, L.C, Bauer, M.A, Jederlinic, P.J, May, J.J, Victory, J.M, Amsden, G.W. The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis. Treat Respir Med 2005;4:117-122.
8. Gursel G. Does coexistence with bronchiectasis influence intensive care unit outcome in patients with chronic obstructive pulmonary disease?. Heart & Lung 2006;35(1):58-65. (Pubitemid 43106636)
9. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560
10. Higgins JPT,Green S (editors). Available fromwww.cochrane-handbook. org. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0 [updated February 2008]. The Cochrane Collaboration (available from www.cochrane- handbook.org.) 2008.
11. Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;232 (7303):42-46 (Pubitemid 32682008)
12. KapurN,ChangAB. Oral non-steroidal anti-inflammatories for children and adults with bronchiectasis. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD006427.pub2]
13. Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E. Non-cysticfibrosis bronchiectasis in children: a persisting problemin developing countries. Respiration 2005;72(3):233-238 (Pubitemid 40981080)
14. Karakoc GB, Yilmaz M, Altintas DU, Kendirli SG. Bronchiectasis: still a problem. Pediatric Pulmonology 2001;32(2):175-178
15. Keistinen T, Saynajakangas O, Tuuponen T, Kivela SL. Bronchiectasis: an orphan disease with a poorly-understood prognosis. European Respiratory Journal 1997;10(12):2784-2787 (Pubitemid 28052788)
16. Lands C, Stanojevic S. Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis (Cochrane Review). Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD001505.pub2] (Pubitemid 351805326)
17. LewisMM, Mortelliti MP, Yeager H Jr, Tsou E. Clinical bronchiectasis complicating pulmonary sarcoidosis: case series of seven patients. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 2002;19(2):154-159 (Pubitemid 34685916)
18. Martinez-Garcia, M.A, Perpina-Tordera, M, Roman-Sanchez, P, Soler-Cataluna, J.J. Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest 2005;128:739-745. (Pubitemid 41140504)
19. Mochizuki H, Ohki Y, Arakawa H, Kato M, Tokuyama K, Morikawa A. Effect of inhaled indomethacin on distilled water-induced airway epithelial cell swelling. Journal of Applied Physiology 2002;92:155-161 (Pubitemid 34670001)
20. Mutalithas, K, Watkin, G, Willig, B, Wardlaw, A, Pavord, I.D, Birring, S.S. Improvement in health status following bronchopulmonary hygiene physical therapy in patients with bronchiectasis. Respir Med 2008;102:1140-1144.
21. O'Brien C, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000;55(8):635-642 (Pubitemid 30468217)
22. Tamaoki J, Chiyotani A, Kobayashi K, Sakai N, Kanemura T, Takizawa T. Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis. American Review of Respiratory Disease 1992;145(3):548-52. * Indicates the major publication for the study